1 – 20 of 29
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prolonged Fatigue and Mental Health Challenges in Critical COVID-19 Survivors
2024) In Journal of Intensive Care Medicine(
- Contribution to journal › Article
-
Mark
Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs : a longitudinal study
(
- Contribution to journal › Article
- 2023
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
(
- Contribution to journal › Article
-
Mark
Impact of SARS-CoV-2 and Other Upper Respiratory Tract Viral Infections on Reproductive Parameters in Young Healthy Men with Mild Symptoms of Disease
(
- Contribution to journal › Article
-
Mark
Management of influenza–updated Swedish guidelines for antiviral treatment
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19 : Protocol for a Pilot Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
- 2021
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter
- 2020
-
Mark
A phase 2 randomized, double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza a virus infection
(
- Contribution to journal › Article
- 2019
-
Mark
A combination of naso- and oropharyngeal swabs improves the diagnostic yield of respiratory viruses in adult emergency department patients
(
- Contribution to journal › Article
- 2018
-
Mark
Eradication of methicillin-resistant Staphylococcus aureus (MRSA) throat carriage : A randomised trial comparing topical treatment with rifampicin-based systemic therapy
(
- Contribution to journal › Article
-
Mark
The majority of MRSA colonized children not given eradication treatment are still colonized one year later. Systemic antibiotics improve the eradication rate
(
- Contribution to journal › Article
-
Mark
Both localized and systemic bacterial infections are predicted by injection drug use : A prospective follow-up study in Swedish criminal justice clients
(
- Contribution to journal › Article
-
Mark
Management of community-acquired pneumonia in immunocompetent adults : updated Swedish guidelines 2017
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Opioid and amphetamine dependence is associated with methicillin-resistant Staphylococcus aureus (MRSA) : An epidemiological register study with 73,201 Swedish in- and outpatients 1997–2013
(
- Contribution to journal › Article
-
Mark
High Perineal and Overall Frequency of Staphylococcus aureus in People Who Inject Drugs, Compared to Non-Injectors
(
- Contribution to journal › Article
- 2016
-
Mark
Flocked nasal swab versus nasopharyngeal aspirate in adult emergency room patients: similar multiplex PCR respiratory pathogen results and patient discomfort.
(
- Contribution to journal › Article
- 2015
-
Mark
LTX-109 is a Novel Agent for Nasal Decolonisation of Methicillin Resistant and Sensitive Staphylococcus aureus.
(
- Contribution to journal › Article
- 2014
-
Mark
Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02(V) in Elderly Adults
(
- Contribution to journal › Article
-
Mark
Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides.
(
- Contribution to journal › Article